Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment

Abstract Background Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with...

Full description

Bibliographic Details
Main Authors: Zofia Kozak, Daniel Ciccarone, Johannes Thrul, Thomas O. Cole, Alexander L. Pappas, Aaron D. Greenblatt, Christopher Welsh, Mark Yoon, Donald Gann, E. Erin Artigiani, Eric D. Wish, Annabelle M. Belcher
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Harm Reduction Journal
Subjects:
Online Access:https://doi.org/10.1186/s12954-023-00745-6
_version_ 1827984801363132416
author Zofia Kozak
Daniel Ciccarone
Johannes Thrul
Thomas O. Cole
Alexander L. Pappas
Aaron D. Greenblatt
Christopher Welsh
Mark Yoon
Donald Gann
E. Erin Artigiani
Eric D. Wish
Annabelle M. Belcher
author_facet Zofia Kozak
Daniel Ciccarone
Johannes Thrul
Thomas O. Cole
Alexander L. Pappas
Aaron D. Greenblatt
Christopher Welsh
Mark Yoon
Donald Gann
E. Erin Artigiani
Eric D. Wish
Annabelle M. Belcher
author_sort Zofia Kozak
collection DOAJ
description Abstract Background Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with opioid use disorder (OUD). We sought to apply this framework to a treatment-seeking population with OUD that may be more inclined to engage in harm reduction behaviors. Methods Patients were recruited from an urban methadone program to complete a survey. We assessed naloxone familiarity, availability, obtainability, training, and possession, as well as naloxone carriage rates, demographics, and harm reduction behaviors. A multivariable logistic regression examined associations between naloxone carriage and individual-level factors. Results Participants (n = 97) were majority male (59%), with a mean age of 48 (SD = 12), 27% had college education or higher, 64% indicated injection drug use, and 84% reported past naloxone training. All participants endorsed familiarity with naloxone, but only 42% regularly carried naloxone. The following variables were associated with carrying naloxone: White race (aOR = 2.94, 95% CI 1.02–8.52), college education (aOR = 8.11, 95% CI 1.76–37.47), and total number of self-reported harm reduction behaviors (aOR = 1.45, 95% CI 1.00–2.11). Conclusion We found low rates of naloxone carriage among methadone-treated patients. Methadone programs provide opportunities for naloxone interventions and should target racial/ethnic minorities and individuals with lower education. The spectrum of harm reduction behaviors should be encouraged among these populations to enhance naloxone carriage.
first_indexed 2024-04-09T23:04:42Z
format Article
id doaj.art-ee9a746d70254540b359ac23912e5186
institution Directory Open Access Journal
issn 1477-7517
language English
last_indexed 2024-04-09T23:04:42Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Harm Reduction Journal
spelling doaj.art-ee9a746d70254540b359ac23912e51862023-03-22T10:48:21ZengBMCHarm Reduction Journal1477-75172023-02-012011610.1186/s12954-023-00745-6Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatmentZofia Kozak0Daniel Ciccarone1Johannes Thrul2Thomas O. Cole3Alexander L. Pappas4Aaron D. Greenblatt5Christopher Welsh6Mark Yoon7Donald Gann8E. Erin Artigiani9Eric D. Wish10Annabelle M. Belcher11Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineDepartment of Family and Community Medicine, University of California, San Francisco School of MedicineDepartment of Mental Health, Bloomberg School of Public Health, Johns Hopkins UniversityDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineCenter for Substance Abuse Research, University of MarylandCenter for Substance Abuse Research, University of MarylandDivision of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of MedicineAbstract Background Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with opioid use disorder (OUD). We sought to apply this framework to a treatment-seeking population with OUD that may be more inclined to engage in harm reduction behaviors. Methods Patients were recruited from an urban methadone program to complete a survey. We assessed naloxone familiarity, availability, obtainability, training, and possession, as well as naloxone carriage rates, demographics, and harm reduction behaviors. A multivariable logistic regression examined associations between naloxone carriage and individual-level factors. Results Participants (n = 97) were majority male (59%), with a mean age of 48 (SD = 12), 27% had college education or higher, 64% indicated injection drug use, and 84% reported past naloxone training. All participants endorsed familiarity with naloxone, but only 42% regularly carried naloxone. The following variables were associated with carrying naloxone: White race (aOR = 2.94, 95% CI 1.02–8.52), college education (aOR = 8.11, 95% CI 1.76–37.47), and total number of self-reported harm reduction behaviors (aOR = 1.45, 95% CI 1.00–2.11). Conclusion We found low rates of naloxone carriage among methadone-treated patients. Methadone programs provide opportunities for naloxone interventions and should target racial/ethnic minorities and individuals with lower education. The spectrum of harm reduction behaviors should be encouraged among these populations to enhance naloxone carriage.https://doi.org/10.1186/s12954-023-00745-6Harm reductionNaloxoneMethadoneOverdose
spellingShingle Zofia Kozak
Daniel Ciccarone
Johannes Thrul
Thomas O. Cole
Alexander L. Pappas
Aaron D. Greenblatt
Christopher Welsh
Mark Yoon
Donald Gann
E. Erin Artigiani
Eric D. Wish
Annabelle M. Belcher
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
Harm Reduction Journal
Harm reduction
Naloxone
Methadone
Overdose
title Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_full Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_fullStr Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_full_unstemmed Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_short Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_sort harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
topic Harm reduction
Naloxone
Methadone
Overdose
url https://doi.org/10.1186/s12954-023-00745-6
work_keys_str_mv AT zofiakozak harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT danielciccarone harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT johannesthrul harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT thomasocole harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT alexanderlpappas harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT aarondgreenblatt harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT christopherwelsh harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT markyoon harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT donaldgann harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT eerinartigiani harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT ericdwish harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT annabellembelcher harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment